Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

CVC Capital Partners to acquire Kobayashi Pharmaceutical

PUBLIC · CVCPYSep 25, 2026

Acquiring Company

CVC Capital Partners

Acquired Company

Kobayashi Pharmaceutical

LondonTokyoFinancial ServicesFinanceVenture CapitalAngel InvestmentHealth CareDietary SupplementsNutrition

Description

CVC Capital Partners is in talks to acquire Kobayashi Pharmaceutical Co. for over $3.2 billion, following a scandal that affected the company's reputation. The deal could take Kobayashi private as it seeks to improve quality controls and manage costs. The acquisition is part of a broader trend of privatizations in Japan's pharmaceutical industry. No formal decisions have been made yet regarding the buyout.

Company Information

Company

CVC Capital Partners

Location

London, England, United Kingdom

About

CVC Capital Partners is a leading private equity and investment advisory firm. Founded in 1981, it has a global presence with investments across various sectors. The firm focuses on generating superior returns through an active partnership with management teams.

Fundz sees it the moment CVC Capital Partners makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Catherine
Senior decision-maker at this company
••••••••@••••••••

See Catherine's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for CVC Capital Partners's next move

Learn about Strategic plan

Frequently asked

Who acquired Kobayashi Pharmaceutical?

Kobayashi Pharmaceutical was acquired by CVC Capital Partners, based in London. The deal was reported on September 25, 2026. CVC Capital Partners is a leading private equity and investment advisory firm. Founded in 1981, it has a global presence with investments across various sectors. CVC Capital Partners is publicly traded (CVCPY) and operates in Financial Services.

When did CVC Capital Partners acquire Kobayashi Pharmaceutical?

CVC Capital Partners's acquisition of Kobayashi Pharmaceutical was reported on September 25, 2026. CVC Capital Partners is in talks to acquire Kobayashi Pharmaceutical Co. for over $3.2 billion, following a scandal that affected the company's reputation. The deal could take Kobayashi private as it seeks to improve quality controls and manage costs. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Kobayashi Pharmaceutical do?

Kobayashi Pharmaceutical Co. is a Japanese health products company known for its range of consumer health products, including eye drops and dietary supplements. The company faced a supplement contamination scandal that has impacted its share value. It is privately held, operating in Health Care, and is based in Tokyo.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.